COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

IRG Summary

Specifically, the OTC IRG reviews research grant applications related to mechanism of action of cancer therapeutic agents in both in vitro and in vivo model systems; development and evaluation of experimental therapies of neoplastic diseases; translation of basic research to clinical practice; development or optimization of treatment modalities; radiation biology and therapy; chemoprevention; and development of biomarkers/signatures for tumor detection and diagnosis.